OPKO Health to Participate in Upcoming September Conferences

Sep 1, 2016

OPKO Health Completes Acquisition of Transition Therapeutics

Aug 31, 2016

Transition Therapeutics Shareholders Approve Acquisition by OPKO Health

Aug 26, 2016

OPKO Health Responds to Law Firm Notice of Investigation

Aug 23, 2016

OPKO Health Reports Improved Financial and Operating Results

Aug 8, 2016

OPKO to Announce Second Quarter Operating and Financial Results on August 8, 2016

Aug 3, 2016

FDA Approves New Drug Application for RAYALDEE® to Treat Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Stage 3-4 Chronic Kidney Disease

Jun 21, 2016

OPKO Health to Host Analyst & Investor Day in New York City on June 15

Jun 14, 2016

OPKO Health Announces Move to NASDAQ Stock Market

Jun 13, 2016

OPKO to Discuss Draft Coverage Determinations for 4Kscore® Test at 2016 Jefferies Healthcare Conference

Jun 7, 2016